Deep Dives, AI, Drug Development, Drug Discovery.
Myers Squibb to help those companies improve their odds in drug discovery and clinical trials respectively. Now Owkin plans to evolve from licensing its research and technology to developing its own intellectual property. The company is a unicorn (firms valued at $1 billion or more) and its big